28% of Mainstays to Face New Price Cuts for Long-Listed Drugs: Jiho Survey

March 7, 2014
Pharmaceutical companies that responded to a recent Jiho survey said that 28% of their 186 flagship products will take price cuts due to a new price reduction rule for long-listed products. Questionnaires were sent to 51 companies, asking about the...read more